Suppose this should technically go under this thread.
J&J partnered with Legend Biotech in an autologous CAR T-cell therapy for melanoma cancers, not dissimilar to OCC's ATI in taking patients cells, cultivating for 4 weeks and then infusing, in a now $500 million deal. That deal went from FDA approval in Feb 2022 to $55 million in quarterly sales by September (many investors were concerned on the timescales and IP of OCC in ATI)
https://www.fiercepharma.com/pharma/carvyktis-growth-sanofi-jj-sell-plants-lg-chems-aveo-buy
"Johnson & Johnson and Legend Biotech’s CAR-T therapy Carvykti racked up $55 million in third-quarter sales. That was up from $24 million in the three months ended in June, the first full quarter it was on the market. The companies are currently working to ramp up manufacturing capacity in anticipation of a year-end phase 3 readout in multiple myeloma patients who had failed one to three prior lines of therapy."
J&J are pegging $5 billion in future sales and Legend BioTech is now a $8 billion USD company by the way:
https://www.fiercepharma.com/pharma/johnson-johnson-legend-car-t-cilta-cel-myeloma-ring-fda-approval-rivaling-bristol-myers
(just a little insight of the potential IF a J&J deal goes through on ATI)
- Forums
- ASX - By Stock
- OCC
- Stem Cell Therapy advancements
Stem Cell Therapy advancements, page-344
-
- There are more pages in this discussion • 115 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OCC (ASX) to my watchlist
|
|||||
Last
36.5¢ |
Change
0.010(2.82%) |
Mkt cap ! $74.31M |
Open | High | Low | Value | Volume |
36.0¢ | 36.5¢ | 35.5¢ | $21.15K | 58.68K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 72154 | 36.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
36.5¢ | 2800 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 72154 | 0.360 |
3 | 22938 | 0.355 |
8 | 179716 | 0.350 |
4 | 89488 | 0.345 |
2 | 45000 | 0.340 |
Price($) | Vol. | No. |
---|---|---|
0.365 | 2800 | 1 |
0.370 | 38570 | 3 |
0.375 | 32756 | 2 |
0.380 | 7845 | 3 |
0.385 | 54712 | 1 |
Last trade - 12.24pm 28/06/2024 (20 minute delay) ? |
Featured News
OCC (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online